Abstract 4371556: Reassessing the Blanking Period: Early Recurrence as a Predictor of Late Atrial Fibrillation Recurrence After Pulsed Field Ablation

J Juan Rodriguez-Riascos (Mayo Clinic Arizona, Scottsdale, Arizona, United States) H Hema Vemulapalli (Mayo Clinic, Phoenix, Arizona, United States) J James Kim A Adivitch Sripusanapan (Mayo Clinic, Phoenix, Arizona, United States) P Poojan Prajapati (Mayo Clinic, Phoenix, Arizona, United States) O Olubadewa Fatunde (Mayo Clinic, Phoenix, Arizona, United States) D Dan Sorajja (Mayo Clinic Arizona, Phoenix, Arizona, United States) H Hicham El Masry (Mayo CLinic AZ, Phoenix, Arizona, United States) W Win Shen (Mayo Clinic Arizona, Phoenix, Arizona, United States) K Komandoor Srivathsan (Mayo Clinic, Phoenix, Arizona, United States)

Abstract

Background: A blanking period allowing for atrial fibrillation (AF) recurrence after pulmonary vein isolation (PVI) has historically been standardized to 90 days. With the recent introduction of pulsed field ablation (PFA) for PVI and emerging in vitro data suggesting a shorter inflammatory timeframe, it remains unclear whether recurrences during this 90-days period reflect incomplete procedural success or merely transient inflammatory changes. Research Question: In patients undergoing PVI with PFA, do early AF recurrences at 30, 60, and 90 days predict late AF recurrences beyond the standardized 90-day blanking period? Methods: Patients undergoing PFA for AF were retrospectively included. Procedures were performed under general anesthesia, and high-density (HD) mapping, with PVI and additional ablation lines applied at the operator’s discretion. PFA catheters included Farawave, PulseSelect, and Sphere-9. AF recurrences were defined as documented episodes on 12-lead ECG or cardiac monitoring devices, confirmed by interpretation from an experienced cardiologist. Survival analyses were conducted based on the occurrence of early recurrences at 30, 60, and 90 days post-ablation. Kaplan-Meier curves and hazard ratios were reported. This study was approved by our institutional review board. Results: To the best of our knowledge, this is the largest real-world study reporting outcomes of PFA for AF in the United States. A total of 1,214 patients were included in the analysis. Mean age was 66.4 years; 31.9% were female, and 22.4% underwent redo PVI. Six-month AF recurrence-free survival was 79% (95% CI, 75–83%) for the overall cohort. Patients experiencing early recurrence at 30, 60, and 90 days had a significantly higher risk of AF recurrence beyond the standardized 90-day blanking period (HR 4.0, 95% CI 2.7–5.9, P < 0.01; HR 5.0, 95% CI 3.6–7.1, P < 0.01; and HR 6.9, 95% CI 4.9–9.6, P < 0.01, respectively). Conclusion: Early recurrences at 30, 60, and 90 days post-ablation are strongly associated with atrial fibrillation recurrence beyond the 90-day blanking period. These findings challenge the traditional concept of blanking period after PFA and suggest that early recurrence may indicate incomplete procedural success rather than transient inflammation.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (10)

J

Juan Rodriguez-Riascos

Mayo Clinic Arizona, Scottsdale, Arizona, United States

H

Hema Vemulapalli

Mayo Clinic, Phoenix, Arizona, United States

J

James Kim

A

Adivitch Sripusanapan

Mayo Clinic, Phoenix, Arizona, United States

P

Poojan Prajapati

Mayo Clinic, Phoenix, Arizona, United States

O

Olubadewa Fatunde

Mayo Clinic, Phoenix, Arizona, United States

D

Dan Sorajja

Mayo Clinic Arizona, Phoenix, Arizona, United States

H

Hicham El Masry

Mayo CLinic AZ, Phoenix, Arizona, United States

W

Win Shen

Mayo Clinic Arizona, Phoenix, Arizona, United States

K

Komandoor Srivathsan

Mayo Clinic, Phoenix, Arizona, United States